Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six ratings firms that are covering the company, MarketBeat reports.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IDEX (NYSE:IEX) and the rest ...
A study published in November in the American Journal of Clinical Pathology that Emerson co-authored validated the analyzer against the Sysmex XN Automated Hematology System and found that CytoChip's ...
A recent study published in Engineering presents an innovative acoustofluidics-based approach for intracellular nanoparticle ...
Redbud has introduced its microfluidics sample prep platform, called Redbud NA1, for use in research and surveillance for ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
After hours: March 12 at 6:13:18 PM EDT Loading Chart for IEX ...